Journal
CANCER
Volume 120, Issue 24, Pages 3862-3865Publisher
WILEY
DOI: 10.1002/cncr.28979
Keywords
-
Categories
Ask authors/readers for more resources
Patients with colorectal cancer have experienced remarkable progress in a range of surgical and oncologic management strategies over the past few years, with a corresponding improvement in survival. The KRAS mutation may be a biomarker of cancer biology and prognosis, but also reflects patient selection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available